Global Tyrosine Kinase Inhibitors Market 2019-2023
About this market
Strategic alliances to trend in the market. The growing prevalence of various diseases increases the demand for innovative therapeutics. TKI therapeutics are one of the most reliable therapeutic options for the treatment of cancer and age-related diseases such as RVO. Technavio’ s analysts have predicted that the tyrosine kinase inhibitors market will register a CAGR of more than 8% by 2023.
Recent approvals of TKIs
Many TKI therapeutic candidates are gaining approval due to their high safety profile and efficacy. The therapeutics that are in last stage of development are expected to get marketing approval during forecast period.
Side effects of TKIs
Despite highly efficacious, TKIs are associated with a spectrum of side effects such as fatigue, muscle cramps, nausea, vomiting, and diarrhea.
For the detailed list of factors that will drive and challenge the growth of the tyrosine kinase inhibitors market during the 2019-2023, view our report.
The market appears to be fragmented and with the presence of several companies including Novartis and Pfizer the competitive environment is quite intense. Factors such as the rising strategic alliances and the recent approvals of TKIs, will provide considerable growth opportunities to tyrosine kinase inhibitors manufactures. Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, Novartis, and Pfizer are some of the major companies covered in this report.
Technavio Announces the Publication of its Research Report – Global Tyrosine Kinase Inhibitors Market 2019-2023
Technavio recognizes the following companies as the key players in the global tyrosine kinase inhibitors market: Bristol-Myers Squibb, F. Hoffmann-La Roche, Johnson & Johnson, Novartis, and Pfizer.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the rising strategic alliances.”
According to the report, one of the major drivers for this market is the recent approvals of TKIs.
Further, the report states that one of the major factors hindering the growth of this market is the side effects of TKIs.
F. Hoffmann-La Roche
Johnson & Johnson
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook